re;
$KIN 07-29-2020 btm.Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart
May 20, 2020
San Francisco, California (May 20, 2020) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company developing novel biologics,
today announced it has entered into an agreement with Vaxart, Inc. (Nasdaq: VXRT) for the manufacture of Vaxart’s oral vaccine candidate for COVID-19.
“We are proud to be contributing toward the effort to develop a COVID-19 vaccine.
We look forward to working with Vaxart to bring this innovative technology to patients as quickly as possible,” said KindredBio’s Chief Executive Officer,
Richard Chin, M.D.
“This marks an important step in the development of our contract manufacturing business, which has the potential to help fund our promising pipeline.”
Under the terms of the agreement, KindredBio will provide manufacturing services from its state-of-the-art biological development and cGMP manufacturing facility in Burlingame, CA.
There, KindredBio will produce the candidate vaccine bulk drug substance under Good Manufacturing Practices,
and provide it to Vaxart to be
formulated into a vaccine tablet to be taken by mouth
instead of by needle injection.
KindredBio will manufacture the vaccine for clinical trials beginning in the second half of 2020.
“We are pleased to be partnering with Kindred Biosciences in the development of our oral COVID-19 vaccine candidate,” said Vaxart’s Chief Executive Officer,
Wouter Latour, M.D.
“We believe our novel approach utilizing a room temperature-stable tablet offers important logistical advantages in widespread oral vaccination,
and that KindredBio with its state-of-the-art manufacturing plants is
an ideal partner to realize our vision.”
KindredBio’s core expertise includes protein engineering,
cell line development,
master cell banking, process development, assay development, stability testing, and
cGMP clinical and
commercial manufacturing from 50 litres to 2,000 litres.
Recent KIN News
- Minutes General Meeting • GlobeNewswire Inc. • 05/15/2024 06:00:00 AM
- Procès-Verbal de l’Assemblée générale • GlobeNewswire Inc. • 05/15/2024 06:00:00 AM
- Payment of dividend • GlobeNewswire Inc. • 05/08/2024 12:03:13 PM
- Paiement dividende • GlobeNewswire Inc. • 05/08/2024 12:03:13 PM
- Business update premier trimestre 2024 • GlobeNewswire Inc. • 04/25/2024 05:00:00 AM
- Business update first quarter 2024 • GlobeNewswire Inc. • 04/25/2024 05:00:00 AM
- Publication du rapport annuel 2023 et convocation à l’Assemblée générale • GlobeNewswire Inc. • 04/05/2024 05:59:59 AM
- Publication of annual report 2023 and convening notice for the General Meeting • GlobeNewswire Inc. • 04/05/2024 05:59:59 AM
- Kinepolis achieved record results in 2023 • GlobeNewswire Inc. • 02/22/2024 06:00:00 AM
- Kinepolis a enregistré des résultats records en 2023 • GlobeNewswire Inc. • 02/22/2024 06:00:00 AM
- Update and end of the share buyback program (19 February 2024) • GlobeNewswire Inc. • 02/19/2024 04:45:05 PM
- Mise à jour et fin du programme de rachat d'actions propres (19 février 2024) • GlobeNewswire Inc. • 02/19/2024 04:45:05 PM
- Update share buyback program (12 February 2024) • GlobeNewswire Inc. • 02/12/2024 04:45:07 PM
- Mise à jour concernant le programme de rachat d'actions propres (12 février 2024) • GlobeNewswire Inc. • 02/12/2024 04:45:07 PM
- Mise à jour concernant le programme de rachat d'actions propres (5 février 2024) • GlobeNewswire Inc. • 02/05/2024 04:47:42 PM
- Update share buyback program (5 February 2024) • GlobeNewswire Inc. • 02/05/2024 04:47:42 PM
- Update share buyback program (29 January 2024) • GlobeNewswire Inc. • 01/29/2024 04:45:05 PM
- Mise à jour concernant le programme de rachat d'actions propres (29 janvier 2024) • GlobeNewswire Inc. • 01/29/2024 04:45:05 PM
- Mise à jour concernant le programme de rachat d'actions propres (22 janvier 2024) • GlobeNewswire Inc. • 01/22/2024 04:45:00 PM
- Update share buyback program (22 January 2024) • GlobeNewswire Inc. • 01/22/2024 04:45:00 PM
- Update share buyback program (15 January 2024) • GlobeNewswire Inc. • 01/15/2024 04:45:18 PM
- Mise à jour concernant le programme de rachat d'actions propres (15 janvier 2024) • GlobeNewswire Inc. • 01/15/2024 04:45:18 PM
- Publication of a transparency notification • GlobeNewswire Inc. • 01/11/2024 05:02:45 PM
- Publication relative à une notification de transparence • GlobeNewswire Inc. • 01/11/2024 05:02:45 PM
- Update share buyback program (8 January 2024) • GlobeNewswire Inc. • 01/08/2024 04:45:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM